Agentix CorpOOTC AGTX Stock Report

Agentix Corp.is a biotechnology company. The company is headquartered in Dana Point, California. The company went IPO on 2015-08-05. The firm is engaged in developing therapeutic agents for the treatment of metabolic disease like Type 2 diabetes mellitus, obesity, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The firm is focused on the development of synthetic agonists, inverse agonists, and antagonists, which modulate the endocannabinoid system (ECS). The ECS is the regulatory system which governs metabolism. Its products include AGTX-2004 and AGTX-2003. The Company’s wholly owned subsidiaries include GSL Healthcare, Inc., AB Merger LLC, Agentix Australia Pty Ltd, and Applied Biopharma.